Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Daly City, California Clinical Trials

A listing of Daly City, California clinical trials actively recruiting patient volunteers.

RESULTS

Found (10) clinical trials

Study to Evaluate Efficacy Safety and Tolerability of MT 7117 in Subjects With Erythropoietic Protoporphyria

This is a Phase II, randomized, double-blind, placebo controlled study to assess the efficacy, tolerability, and safety of MT-7117 in subjects with EPP. The study consists of a 2 week screening period, a 16 week double-blind treatment period, and a 6 week follow-up period at Week 22. The total participation ...

Phase

5.23 miles

Learn More »

Enhanced Stress Resilience Training for Residents

Experiencing joy in the practice of medicine is by no means guaranteed. For many physicians, the unique bond with patients, the deep satisfaction of saving a life, and a profound sense of calling make the sacrifice and heartache worthwhile. In contrast, the growing prevalence of burnout and mental distress in ...

Phase N/A

5.23 miles

Learn More »

Enhanced Stress Resilience Training for Faculty

Investigators believe the myriad positive effects of Mindfulness training are due to the very central mechanistic effect of mindfulness training on the brain. This is a critical facet of mindfulness mental training in particular because it is the centrality of the training effect that allows it to be meaningful through ...

Phase N/A

5.23 miles

Learn More »

Inpatient Clinical Trial of NAC

N-acetylcystine (NAC) is a mucolytic medication, meaning that it breaks apart mucus. Investigators know that mucus is a factor in severe asthma attacks. However, mucus may be a factor in chronic severe asthma as well. This role has been hard to prove because of difficulty in showing that mucus occludes ...

Phase

5.23 miles

Learn More »

Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer

Patients with serious cancers, like advanced lung cancer, often experience physical symptoms, such as pain or shortness of breath. In addition, both patients and their loved ones (family and friends) often feel worried or sad about the cancer diagnosis. Research has shown that early involvement of a team of clinicians ...

Phase N/A

6.35 miles

Learn More »

A Study Evaluating ABI-H0731+ NUC vs NUC Alone for the Treatment of Viremic HBeAg-positive CHB Patients

This is a Phase 2a, Multi-center, Double-blind, Placebo-controlled Study Evaluating ABI-H0731+ Entecavir vs Entecavir Alone for the Treatment of Viremic HBeAg-positive Patients With Chronic Hepatitis B

Phase

7.01 miles

Learn More »

Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma

Over 180,000 diagnoses of invasive breast cancer are made in the US each year. Over onethird of women with early stage and over half with latestage breast cancer are treated with mastectomy (removal of the entire breast) due to tumor size, multiple cancers within the breast, genetic cancer predisposition, and/or ...

Phase N/A

7.01 miles

Learn More »

A Study Evaluating ABI-H0731 as Adjunctive Therapy in HBeAg-positive Patients With Chronic Hepatitis B

This is a Phase 2a, Multi-center, Double-blind, Placebo-controlled Study Evaluating ABI-H0731 as Adjunctive Therapy in Virally-suppressed HBeAg-positive Patients with Chronic Hepatitis B

Phase

7.01 miles

Learn More »

A Study of JNJ-63723283 a Programmed Cell Death Receptor-1 (PD-1) Inhibitor Administered in Combination With Apalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer

This study is of participants with mCRPC who have progressed after therapy with an androgen receptor (AR)-targeted agent and have not received chemotherapy. Participants must have confirmed prostate-specific antigen (PSA) progression per Prostate Cancer Clinical Trials Working Group (PCWG3) criteria. The primary hypothesis is that treatment with JNJ-63723283 and apalutamide ...

Phase

7.52 miles

Learn More »

DDI Effectiveness and Clinical Awareness

The DECART study is a pre-post, two round, randomized controlled study of a nationally representative sample of 330 primary care physicians randomly assigned to a control or one of two intervention arms. Once eligibility is determined and providers are enrolled in the study, they will be asked to complete a ...

Phase N/A

7.7 miles

Learn More »